Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 134.20% vs 2.07% in Sep 2025
Standalone Net Profit
YoY Growth in quarter ended Sep 2026 is 44.42% vs -72.98% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 100.44% vs -110.60% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 187.37% vs 37.68% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Oxygenta Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -9.49% vs -25.42% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 134.20% vs 2.07% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is -30.48% vs -23.53% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 44.42% vs -72.98% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -96.36% vs 400.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 100.44% vs -110.60% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 10.98% vs 35.91% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 187.37% vs 37.68% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025